RENEO PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.67 USD | +1.21% |
|
-4.02% | +4.38% |
| 03-28 | Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
Chart calendar Reneo Pharmaceuticals, Inc.
77ab4c3d184c6aec75c20b.1UQ_rxL-dIOMb1jKg5oBLXY3gk5HBhmK3bY--DNuMzE.oiJV11CdR7vhGy-w0fJQZhVC5AJ2bF_Tu_BTi3UWVwGeNXXWQbs7zflbLw~172d31642530cade278697248ef749f1
Upcoming events on Reneo Pharmaceuticals, Inc.
Past events on Reneo Pharmaceuticals, Inc.
| 28/03/2024 11:35 | Q4 2023 Earnings Release |
| 13/11/2023 12:35 | Q3 2023 Earnings Release |
| 06/11/2023 22:30 | Translational Research in Mitochondria Metabolism Aging and Disease Meeting |
| 25/10/2023 19:00 | PittGene Meeting |
| 10/10/2023 | Jefferies Inaugural Biotech CNS/Neuro Summit |
| 09/10/2023 17:00 | Investor Meeting - Key Opinion Leader |
| 27/09/2023 14:00 | Cantor Global Healthcare Conference |
| 20/09/2023 16:00 | Leerink Partners Biopharma Summit |
| 12/09/2023 14:00 | Baird Global Healthcare Conference |
| 06/09/2023 14:00 | Citi BioPharma Conference |
| 10/08/2023 12:35 | Q2 2023 Earnings Release |
| 10/07/2023 | SVB Securities Therapeutics Forum |
| 30/06/2023 16:30 | UMDF Mitochondrial Medicine Symposium - Platform Session 5 |
| 29/06/2023 22:45 | UMDF Mitochondrial Medicine Symposium - PPAR? Agonist Mavodelpar (REN001) |
| 29/06/2023 22:45 | UMDF Mitochondrial Medicine Symposium - Clinical Manifestations and Disease Burden |
| 28/06/2023 22:30 | UMDF Mitochondrial Medicine Symposium - Clinical Manifestations |
| 28/06/2023 22:30 | UMDF Mitochondrial Medicine Symposium - Mavodelpar Clinical Development |
| 10/06/2023 | Euromit Bologna Conference |
| 07/06/2023 16:00 | Jefferies Global Healthcare Conference |
| 06/06/2023 19:30 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -39,8 -43,2 7.87% | -53,8 -54,0 0.2% | -83,1 -78,8 -5.43% | -40,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -39,8 -43,3 8.14% | -52,0 -52,8 1.66% | -77,4 -74,7 -3.6% | -34,1 |
|
Net income Million USD | Released Forecast Spread | -19,5 | -39,8 -43,2 7.84% | -52,0 -53,0 1.89% | -77,4 -73,4 -5.41% | -35,8 |
|
EPS USD | Released Forecast Spread | -9,58 | -2,19 -3,23 32.27% | -2,12 -2,16 1.62% | -2,52 -2,36 -7.01% | -0,99 |
| Announcement Date | 19/03/21 | 23/03/22 | 27/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -10,6 -14,0 24.25% | -13,0 -12,9 -0.8% | -12,4 -14,1 12.02% | -13,8 -13,6 -2.06% | -14,6 -14,7 0.73% | -16,1 -15,2 -6.27% | -21,0 -16,3 -28.75% | -20,9 -20,9 0.22% | -25,0 -20,7 -20.67% | -17,0 | -8,73 | -7,71 | -6,90 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,6 -14,1 24.98% | -13,0 -12,7 -2.61% | -12,3 -14,1 12.74% | -13,0 -14,0 7.31% | -13,6 -14,5 5.91% | -15,1 -14,9 -1.43% | -19,5 -16,3 -19.96% | -19,2 -21,0 8.37% | -23,6 -20,9 -12.82% | -15,0 | -6,57 | -6,19 | -6,33 |
|
Net income Million USD | Released Forecast Spread | -10,6 -14,0 24.19% | -13,0 -12,8 -2.01% | -12,3 -14,1 12.74% | -13,0 -13,5 3.78% | -13,6 -14,6 6.7% | -15,1 -14,8 -1.83% | -19,5 -16,1 -21.5% | -19,2 -20,2 4.99% | -23,6 -19,6 -20.4% | -15,8 | -7,60 | -6,59 | -5,78 |
|
EPS USD | Released Forecast Spread | -0,37 -0,57 35.09% | -0,53 -0,52 -1.92% | -0,50 -0,57 12.28% | -0,53 -0,55 3.05% | -0,55 -0,59 6.38% | -0,60 -0,60 0.66% | -0,65 -0,49 -32.65% | -0,57 -0,61 7.17% | -0,71 -0,57 -24.56% | -0,43 | -0,19 | -0,17 | -0,17 |
| Announcement Date | 23/03/22 | 10/05/22 | 09/08/22 | 08/11/22 | 27/03/23 | 11/05/23 | 10/08/23 | 13/11/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for Reneo Pharmaceuticals, Inc.
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RPHM Stock
- Calendar Reneo Pharmaceuticals, Inc.
